Rankings
▼
Calendar
AMPH Q2 2021 Earnings — Amphastar Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
AMPH
Amphastar Pharmaceuticals, Inc.
$860M
Q2 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$102M
+18.5% YoY
Gross Profit
$47M
46.6% margin
Operating Income
$11M
10.4% margin
Net Income
$8M
7.6% margin
EPS (Diluted)
$0.16
QoQ Revenue Growth
-1.3%
Cash Flow
Operating Cash Flow
$32M
Free Cash Flow
$26M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$666M
Total Liabilities
$199M
Stockholders' Equity
$422M
Cash & Equivalents
$125M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$102M
$86M
+18.5%
Gross Profit
$47M
$33M
+42.8%
Operating Income
$11M
-$3M
+461.4%
Net Income
$8M
-$192,000
+4145.3%
Revenue Segments
Active Pharmaceutical Ingredient Segment
$7M
100%
Geographic Segments
U
$95M
99%
C
$1M
1%
← FY 2021
All Quarters
Q3 2021 →